DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Proarrhythmia
Proarrhythmia
Drugs and Life-Threatening Ventricular Arrhythmia Risk: Results from the DARE Study Cohort
An Electrocardiographic Series of Flecainide Toxicity
Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic Effects Tulay Akman1,2, Oytun Erbas3, Levent Akman4,5, Ahmet U
Efficacy and Proarrhythmia of Oral Sotalol in Pediatric Patients
Drug-Induced Proarrhythmia: Discussion and Considerations for Clinical Practice Ralph J
Get in Rhythm with the Safe and Effective Use of Antiarrythmic Drugs
Proarrhythmia and Primum Non Nocere
Risk of Proarrhythmic Events in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study a Multivariate Analysis Elizabeth S
LANOXIN (Digoxin) Tablets, for Oral Use the Overall Incidence of Adverse Reactions with Digoxin Has Been Reported As Initial U.S
Rechanneling the Cardiac Proarrhythmia Safety Paradigm: an Update Synopsis of the December 11Th, 2014 FDA/CSRC/HESI/SPS Think Tank Meeting
Drug-Induced QT-Interval Prolongation and Proarrhythmic Risk
Antiarrhythmic Drugs.Pdf
New Investigational Drugs for the Management of Acute Heart Failure Syndromes
Flecainide Induced Ventricular Arrhythmias in Atrial Fibrillation Manish Barman* and Bendaas Djamel Department of Cardiology, Al Ahli Hospital, Doha, Qatar
SOTALOL 1. Product Name 2. Qualitative and Quantitative
Arrhythmogenic Mechanisms in Heart Failure Johnson, Daniel
Digoxin Oral Solution Label
Therapeutic Alternatives in Atrial Fibrillation
Top View
Treatment of Fetal Arrhythmias
Ventricular Tachycardia in Association with Propafenone Overdose
Proposed Ion Channel Panel